These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 19664616)

  • 1. Evaluation of amphetamine-induced hyperlocomotion and catalepsy following long-acting risperidone administration in rats.
    Marchese G; Casu G; Casti P; Spada GP; Pani L
    Eur J Pharmacol; 2009 Oct; 620(1-3):36-41. PubMed ID: 19664616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated antipsychotic treatment progressively potentiates inhibition on phencyclidine-induced hyperlocomotion, but attenuates inhibition on amphetamine-induced hyperlocomotion: relevance to animal models of antipsychotic drugs.
    Sun T; Hu G; Li M
    Eur J Pharmacol; 2009 Jan; 602(2-3):334-42. PubMed ID: 19059234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
    Tada M; Shirakawa K; Matsuoka N; Mutoh S
    Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical review of a long-acting, injectable formulation of risperidone.
    Knox ED; Stimmel GL
    Clin Ther; 2004 Dec; 26(12):1994-2002. PubMed ID: 15823763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ST2472: a new potential antipsychotic with very low liability to induce side-effects.
    Stasi MA; Di Serio S; Vertechy M; Schiavone A; Ghirardi O; Minetti P; Campiani G; Borsini F; Carminati P
    Int J Neuropsychopharmacol; 2008 May; 11(3):309-19. PubMed ID: 17925059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral disinhibition and depression in amphetaminized rats: a comparison of risperidone, ocaperidone and haloperidol.
    Megens AA; Niemegeers CJ; Awouters FH
    J Pharmacol Exp Ther; 1992 Jan; 260(1):160-7. PubMed ID: 1370539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioural effects of chronic haloperidol and risperidone treatment in rats.
    Karl T; Duffy L; O'brien E; Matsumoto I; Dedova I
    Behav Brain Res; 2006 Aug; 171(2):286-94. PubMed ID: 16697060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cinnarizine has an atypical antipsychotic profile in animal models of psychosis.
    Dall'Igna OP; Tort AB; Souza DO; Lara DR
    J Psychopharmacol; 2005 Jul; 19(4):342-6. PubMed ID: 15982988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Catalepsy and hyperkinesis induced by the chronic administration of a tetrapeptide into the rat neostriatum].
    Iakimovskiĭ AF
    Fiziol Zh SSSR Im I M Sechenova; 1991 Jan; 77(1):22-8. PubMed ID: 1652493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated risperidone administration during puberty prevents the generation of the aggressive phenotype in a developmentally immature animal model of escalated aggression.
    Schwartzer JJ; Connor DF; Morrison RL; Ricci LA; Melloni RH
    Physiol Behav; 2008 Sep; 95(1-2):176-81. PubMed ID: 18617196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8-13) analogues containing non-natural arginine and lysine residues.
    Hadden MK; Orwig KS; Kokko KP; Mazella J; Dix TA
    Neuropharmacology; 2005 Dec; 49(8):1149-59. PubMed ID: 16095636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of acute or chronic administration of risperidone on motor and sexual behavior of male rats.
    Drago F; Contarino A; Marino R; Anzallo C; Valerio C; Rampello L; Raffaele R; Scapagnini U
    Pharmacol Res; 1997 Jan; 35(1):17-25. PubMed ID: 9149311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The d-amphetamine-treated Göttingen miniature pig: an animal model for assessing behavioral effects of antipsychotics.
    van der Staay FJ; Pouzet B; Mahieu M; Nordquist RE; Schuurman T
    Psychopharmacology (Berl); 2009 Nov; 206(4):715-29. PubMed ID: 19626314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic risperidone treatment on the striatal protein profiles in rats.
    O'Brien E; Dedova I; Duffy L; Cordwell S; Karl T; Matsumoto I
    Brain Res; 2006 Oct; 1113(1):24-32. PubMed ID: 16938284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-lasting sensitization induced by repeated risperidone treatment in adolescent Sprague-Dawley rats: a possible D2 receptor mediated phenomenon?
    Qiao J; Gao J; Shu Q; Zhang Q; Hu G; Li M
    Psychopharmacology (Berl); 2014 Apr; 231(8):1649-1659. PubMed ID: 24363078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DPP IV inhibitor blocks mescaline-induced scratching and amphetamine-induced hyperactivity in mice.
    Lautar SL; Rojas C; Slusher BS; Wozniak KM; Wu Y; Thomas AG; Waldon D; Li W; Ferraris D; Belyakov S
    Brain Res; 2005 Jun; 1048(1-2):177-84. PubMed ID: 15925329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic administration of quetiapine alleviates the anxiety-like behavioural changes induced by a neurotoxic regimen of dl-amphetamine in rats.
    He J; Xu H; Yang Y; Zhang X; Li XM
    Behav Brain Res; 2005 May; 160(1):178-87. PubMed ID: 15836913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tryptophan and valine administration on behavioral pharmacology of haloperidol.
    Ali O; Haleem DJ; Saify ZS; Kamil N; Obaid R; Ahmed SW
    Pak J Pharm Sci; 2005 Apr; 18(2):23-8. PubMed ID: 16431394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short- and long-term effects of risperidone on catalepsy sensitisation and acquisition of conditioned avoidance response: Adolescent vs adult rats.
    Moe AAK; Medely GA; Reeks T; Burne THJ; Eyles DW
    Pharmacol Res; 2017 Jul; 121():1-13. PubMed ID: 28414178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective tolerance to the hypothermic and anticataleptic effects of a neurotensin analog that crosses the blood-brain barrier.
    Boules M; McMahon B; Wang R; Warrington L; Stewart J; Yerbury S; Fauq A; McCormick D; Richelson E
    Brain Res; 2003 Oct; 987(1):39-48. PubMed ID: 14499944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.